explore -WSS

explore

author：entertainment 2025-09-06 08:39:27 - browse：9737

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： How to keep neuroscience’s past racism from being its future

WSS

Change Healthcare payments predicted restored March 15

Just how do doctors, lawmakers, and the public define abortion?

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Change Healthcare payments predicted restored March 15

What it’s like to watch children die of measles

Why health care costs have stayed mostly flat since 2010

hotspot

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Sen. Paul opposes bill to ban Chinese biotechs

After affirmative action ruling, medical educators look to 'holistic review'

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Psychedelics group wrestles with new pharma identity

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Guidelines to prevent youth baseball injuries need more muscle

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Affirmative action in medical school literally saved lives

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

focus

Readout Newsletter: The latest on Moderna, Apellis, and Merck

With psoriasis trial ahead, Alumis raises $259 million

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

Why health records don't always know when patients are dead

CDC marks new Covid

What STAT readers think about the FDA and patient advocacy

focus

explore

knowledge

knowledge